"Growth hormone treatment and adverse events in Prader-Willi syndrome: Data from KIGS (the Pfizer International Growth Database)." by Edward Reiter, MD

Article

Growth hormone treatment and adverse events in Prader-Willi syndrome: Data from KIGS (the Pfizer International Growth Database).

All Scholarly Works

Edward Reiter, MD, Baystate Health

Document Type

Article, Peer-reviewed

Publication Date

8-1-2006

Abstract

OBJECTIVE: To evaluate the response to recombinant GH treatment and adverse events in children with Prader-Willi syndrome (PWS) from KIGS, the Pfizer International Growth Database. PATIENTS: A total of 328 children (274 prepubertal, median age 6.0 years;

Publication ISSN

0884-8734

Citation Information

Clin Endocrinol (Oxf). 2006 Aug;65(2):178-85.